BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 4325820)

  • 1. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy.
    Goldstein DP
    Am J Obstet Gynecol; 1971 Jun; 110(4):583-7. PubMed ID: 4325820
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum placental lactogen levels in patients with molar pregnancy and trophoblastic tumors.
    Saxena B; Goldstein DP; Emerson K; Selenkow HA
    Am J Obstet Gynecol; 1968 Sep; 102(1):115-21. PubMed ID: 4299677
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioimmunoassay of serum chorionic gonadotropin and placental lactogen in trophoblastic disease.
    Yen SS; Pearson OH; Rankin JS
    Obstet Gynecol; 1968 Jul; 32(1):86-93. PubMed ID: 4316070
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB; Lehr M; Lewis JL
    Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
    [No Abstract]   [Full Text] [Related]  

  • 5. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM; Seppälä M
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
    Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chorionic growth hormone-prolactin (CGP): secretion, disposition, biologic activity in man, and postulated function as the "growth hormone" of the 2d half of pregnancy.
    Grumbach MM; Kaplan SL; Sciarra JJ; Burr IM
    Ann N Y Acad Sci; 1968 Feb; 148(2):501-31. PubMed ID: 5239684
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of early pregnancy factor-like activity in women with gestational trophoblastic tumors.
    Mehta AR; Shahani SK
    Am J Reprod Immunol Microbiol; 1987 Jul; 14(3):67-9. PubMed ID: 2823620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
    Lee JN; Salem HT; Al-Ani AT; Chard T; Huang SC; Ouyang PC; Wei PY; Seppälä M
    Am J Obstet Gynecol; 1981 Mar; 139(6):702-4. PubMed ID: 6971058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the systematic use of serial estimation of human placental lactogen (hPL) and human chorionic gonadotropin (hCG) for the management of trophoblastic neoplasia.
    Chough SY
    Endocrinol Jpn; 1973 Feb; 20(1):9-21. PubMed ID: 4353253
    [No Abstract]   [Full Text] [Related]  

  • 13. Laboratory assessment of disappearance patterns of human chorionic gonadotropin from serum of patients with gestational trophoblastic disease.
    Boots LR; Hatch KD; Younger JB
    Ala J Med Sci; 1983 Oct; 20(4):391-4. PubMed ID: 6316799
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum human placental lactogen (HPL) levels in patients with intact hydatidiform mole.
    Lim YC; Chew SC; Ratnam SS
    Acta Obstet Gynecol Scand; 1976; 55(5):407-12. PubMed ID: 187001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum progesterone during treatment of malignant trophoblastic disease.
    Dawood MY
    Am J Obstet Gynecol; 1975 Oct; 123(3):291-8. PubMed ID: 170826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro biosynthesis of human placental lactogen (HPL) by chorionic tissue and the diagnostic value of HPL in trophoblastic disease.
    Sato Y
    Endocrinol Jpn; 1973 Jun; 20(3):291-306. PubMed ID: 4357807
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma androstenedione (A) and dihydrotesto-terone (DHT) in patients with trophoblastic disease and the effect of chemotherapy and oophorectomy.
    Samaan NA; Smith JP; Rutledge FN
    Gynecol Invest; 1973; 4(5-6):237-42. PubMed ID: 4373314
    [No Abstract]   [Full Text] [Related]  

  • 20. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
    Khoo SK; Daunter B
    Aust N Z J Obstet Gynaecol; 1980 Feb; 20(1):35-42. PubMed ID: 6248013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.